Open AccessClinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
Author(s) -
Yu Li,
Dongzi Yang,
Qingxue Zhang
Publication year - 2012
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.97785
Subject(s) - triptorelin , leuprorelin , medicine , in vitro fertilisation , pregnancy rate , luteinizing hormone , gonadotropin releasing hormone agonist , luteal phase , depot , andrology , pregnancy , gynecology , hormone , endocrinology , gonadotropin releasing hormone , biology , history , archaeology , genetics
Appropriate dosage of the long-acting depot gonadotrophin releasing hormone (GnRH) agonist has not been determined in long protocol for IVF, and one-third-dose depot triptorelin was compared with half-dose in a luteal long protocol of in-vitro fertilization/ intra cytoplasmic sperm injection (IVF/ICSI) treatment in this study.